Home / Services / Research & Development / Stem Cell Facilitated Drug Discovery / Age related Macular Degeneration / PEDF Secretion Assay

RPE secretome assay development

PEDF Secretion Assay

Measure how RPE models release pigment epithelium-derived factor in response to maturation, stress, and candidate compounds—with a study design built for meaningful conditioned-medium comparisons.

Start a PEDF Study Talk to a Scientist

Why measure secreted PEDF?

Turn conditioned medium into a functional RPE readout

Pigment epithelium-derived factor is released by retinal pigment epithelium and is studied in retinal homeostasis, neuroprotection, and angiogenic balance. Quantifying PEDF in culture supernatant adds a functional layer to iPSC-facilitated AMD discovery that intracellular marker data alone cannot provide.

The assay is configured around a precise comparison rather than a generic protein measurement. Collection timing, medium volume, culture maturity, cell health, and normalization are aligned before execution.

  • ?
    Does a candidate compound increase or suppress PEDF release?
  • ?
    Does secretion change as an iPSC-derived RPE culture matures?
  • ?
    Is the effect retained after correction for viable cell number?
  • ?
    How does PEDF change alongside VEGF under the same condition?

PEDF Secretion Study Architecture

01 · Model

Choose the biological context

Define RPE source, differentiation stage, passage, plate or Transwell format, and baseline phenotype.

02 · Perturbation

Control the exposure

Set test articles, vehicle controls, dose levels, exposure duration, and biological replication.

03 · Collection

Standardize the medium

Fix the sampling window, volume, compartment, storage conditions, and normalization denominator.

Assay configuration

One secretion assay, four design decisions

Creative Biolabs can integrate PEDF analysis into a customized stem cell-based assay development program. Each module is selected according to the model and the decision the data must support.

A01

Quantitative ELISA

Measure PEDF in conditioned medium against a standard curve with study-specific sample dilution and technical replication.

A02

Normalization Strategy

Relate secretion to viable cells, total cellular protein, culture area, or collection duration to support between-group comparison.

A03

Directional Sampling

Collect apical and basal compartments separately when a polarized Transwell RPE system is part of the agreed study.

Project workflow

A controlled chain from culture to concentration

Every stage has a defined checkpoint, so sample handling and normalization decisions are recorded before the final comparison is made.

01

Design

Lock the model, groups, controls, replicates, collection interval, and reporting endpoint.

Checkpoint: approved study map

02

Culture & Dose

Prepare the RPE model, apply the agreed perturbation, and document culture condition and timing.

Checkpoint: treatment record

03

Collect & Quantify

Harvest conditioned medium consistently and quantify PEDF with standards, controls, and replicates.

Checkpoint: accepted assay run

04

Normalize & Interpret

Apply the agreed denominator, compare groups, and integrate complementary endpoints where included.

Checkpoint: final data report

What you receive

Data that can be traced back to the collection plan

The final package is configured during project scoping and can include raw, calculated, normalized, and visual outputs.

  • Study map and conditioned-medium collection record
  • Standard curve, raw absorbance, and dilution details
  • Calculated PEDF concentration for each sample
  • Normalized values, fold changes, and agreed statistics
  • Summary figures, method notes, and final report

What we confirm

Project-readiness checklist

These inputs determine whether the resulting secretion values can be compared without avoidable ambiguity.

  1. RPE source, maturity, passage, and culture geometry
  2. Test article, vehicle, concentrations, and exposure duration
  3. Medium composition, sampling interval, and collection volume
  4. Biological and technical replicate structure
  5. Normalization method and desired reporting format

Research applications

Use PEDF where secretion behavior matters

The assay can be positioned as a compound-response endpoint, an RPE maturation measure, or one component of a broader secretome and phenotype strategy.

Have a conditioned-medium study in mind?

Share the RPE model, treatment groups, collection window, and preferred normalization approach.

Scope the Project

Frequently asked questions

Planning a PEDF secretion study

What does a PEDF secretion assay measure?

The assay quantifies pigment epithelium-derived factor released into conditioned culture medium. Results can be reported as concentration, normalized secretion, or fold change relative to a control condition.

Which samples can be used for PEDF secretion analysis?

Projects may use conditioned medium collected from RPE cells, iPSC-derived RPE cultures, or another agreed research cell model. Medium composition, collection timing, storage, expected range, and sample volume are reviewed before testing.

Can PEDF be measured together with VEGF?

Yes. A paired design can quantify both factors when the study requires evaluation of anti-angiogenic and pro-angiogenic balance. The appropriate interpretation depends on the model, treatment, viability, and normalization strategy.

How can PEDF secretion be normalized?

Depending on the culture system, PEDF may be normalized to viable cell number, total cellular protein, culture area, collection duration, or another agreed denominator. The same collection and normalization method should be applied across comparison groups.

Is this assay intended for clinical use?

No. This service is for research use only and is not intended for diagnostic or clinical use.

Online Inquiry

For Research Use Only. Not For Clinical Use.